Welcome to our comprehensive ‘Resources’ section at Miller’s Pharmacy, where we provide a wealth of information and tools designed to support and empower your healthcare journey. Understanding and managing your medication has never been easier with our intuitive Medication Lookup Tool, offering detailed insights into various drugs, their uses, and potential side effects. For your convenience, we’ve also compiled an array of essential Medical Document Downloads, providing easy access to forms and information crucial for your health management. Additionally, stay informed with our live FDA Drug Alert Feed, a valuable resource that keeps you updated on the latest drug safety news and alerts directly from the FDA. This page is tailored to enhance your healthcare experience by providing easy access to important information and resources, ensuring you have everything you need for informed health decisions right at your fingertips.
Pharmacy Resources
Downloads
EUA COVID-19 Vaccine Fact Sheet for
Recipients and Caregivers
FDA Drug Alerts
- FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition
- FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy
- Eugia US LLC Issues Recall of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single Dose Vial) Due to Presence of Particulate Matter
- Counterfeit Versions of Eye Drops Found in Several States
- Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
- Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial Due to the Presence of Particulate Matter
- FAERS Receives Increased Reports of Allergic/Hypersensitivity Reactions with One Lot of Immune Globulin Intravenous (IGIV)
- Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
- FDA Takes Action on New Boxed Warning for Adzynma Enzyme Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
